Come and join us across the globe
LINNC China 2025 LINNC Seminar 2025 - Asia Edition LINNC Seminar 2026 - Americas Edition LINNC Paris 2026
 Founded by Pr. Jacques Moret 
Sign In
Come and join us across the globe
LINNC China 2025 LINNC Seminar 2025 - Asia Edition LINNC Seminar 2026 - Americas Edition LINNC Paris 2026
 Founded by Pr. Jacques Moret 
INR stories: Ajay Wakhloo's uncensored interview
Key clinical and technological shifts in neurointervention at ABC WIN 2026
Discover the program
Treatment of a previously ruptured aneurysm with multiple recurrence
Cases
view more
Use of a unique distal-shaped microcatheter in the treatment of a wide-neck Acom aneurysm
October 27, 2025
Right MCA aneurysm treated with intrasaccular flow diversion after two failed attempts
October 20, 2025
BADDASS approach to right M1 revascularization
October 20, 2025
One&Done coiling for tiny aneurysms
September 29, 2025
A must-have guide for all the neurointerventionalists
20 years of INR trials in one unique synthetic format
Get your book now
INR Trials
LINNC TV
view more
How can we make AVM endovascular treatment great again?
Over 100 Artisse cases: Real-world experience from Montpellier
Advances and future perspectives in stroke care and neurointervention in Singapore
Press releases
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
February 11, 2026
Vesalio, a global leader in vascular intervention, today announced CE Mark certification and the European commercial launch of two new neurovascular devices: NeVa™ VS, for the treatment of cerebral...
Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke
February 9, 2026
TIGERTRIEVER™ 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic...
Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology
December 12, 2025
The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio’s commercial platform.Plano, Texas – Dec 11, 2025
Vesalio Receives Two FDA 510(k) Clearances, Advancing Its Comprehensive Thrombectomy Platform with Aspiration Technology
November 19, 2025
The FDA clearances expand Vesalio’s thrombectomy portfolio to support its growth strategy in the rapidly expanding multi-billion-dollar global thrombectomy market.Plano, Texas – November 18, 2025
Congresses
view more
SFNR 2026
SFNR
March 11, 2026 - March 13, 2026
Congrès de la Société Française de NeuroRadiologie
SNIS congress
SNIS congress
July 20, 2026 - July 24, 2026
Society of NeuroInterventional Surgery
ESMINT congress
ESMINT congress
September 2, 2026 - September 4, 2026
European Society of Minimally Invasive Neurological Therapy
SVIN 26
SVIN Annual meeting
November 18, 2026 - November 20, 2026
Society of Vascular and Interventional Neurology 
LINNC online is supported by an educational grant from
Balt Medtronic Terumo Neuro Stryker Vesalio Route 92 Wallaby Phenox